Edwards Lifesciences (EW) PT Raised to $105 at Piper Sandler
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $85.88 --0%
Rating Summary:
29 Buy, 16 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 5
Rating Summary:
29 Buy, 16 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 5
Join SI Premium – FREE
Piper Sandler analyst Adam Maeder raised the price target on Edwards Lifesciences (NYSE: EW) to $105.00 (from $97.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades QIAGEN NV (QIA:GR) (QGEN) to Overweight
- Morgan Stanley Upgrades Demant A/S (DEMANT:DC) (WILYY) to Overweight
- Smith & Nephew PLC. (SN:LN) (SNN) PT Lowered to GBP13.33 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
